<DOC>
<DOCNO>
EP-0008824
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
A61P-25/02 A61K-31/58 A61P-25/00 <main>C07J-43/00</main> C07J-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same.
</TITLE>
<APPLICANT>
akzo nvnl<sep>akzo n.v. <sep>akzo n.v.velperweg 76nl-6824 bm arnhem nl  <sep>akzo n.v.<sep>
</APPLICANT>
<INVENTOR>
carlyle ian craig<sep>savage david samuel<sep>sleigh thomas<sep>carlyle, ian craig<sep>savage, david samuel<sep>sleigh, thomas<sep>carlyle, ian craig35 balfron crescenthamilton - scotlandgb<sep>savage, david samuel32 beech avenuenewton mearns glasgow - scotlandgb<sep>sleigh, thomas3 coulter avenuewishaw - scotlandgb<sep>carlyle, ian craig<sep>savage, david samuel<sep>sleigh, thomas <sep>carlyle, ian craig 35 balfron crescent hamilton - scotlandgb<sep>savage, david samuel32 beech avenuenewton mearns glasgow - scotlandgb<sep>sleigh, thomas3 coulter avenuewishaw - scotlandgb<sep>
</INVENTOR>
<ABSTRACT>
new and pharmacologically useful pharmaceutically  acceptable acid addition salts are disclosed for the  16β-monoquaternary ammonium derivatives of either the  2β,16β-bis- piperidino-3α, 17β-dihydroxy-5α- androstane  3α,17β-di-lower aliphatic esters the 2β,16β-bis-­ piperidino-3α-hydroxy- 5α-androstane-3α- lower aliphatic  esters, which salts are surprisingly relatively stable in aque­ ous solutions, so that they provide stable aqueous injection  preparations.  the compounds are highly active neuromuscu­ lar blocking agents with quick onset and short duration of  action and devoid of cardiovascular side-effects.  
</ABSTRACT>
</TEXT>
</DOC>
